Detalles de la búsqueda
1.
Evolving patterns and clinical outcome of genetic studies performed at diagnosis in acute myeloid leukemia patients: Real life data from the PETHEMA Registry.
Cancer;
2024 Jun 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38896056
2.
Impact of trisomy 19 on outcome according to genetic makeup in patients with acute myeloid leukemia.
Haematologica;
108(8): 2059-2066, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36815361
3.
A phase 3 trial of azacitidine versus a semi-intensive fludarabine and cytarabine schedule in older patients with untreated acute myeloid leukemia.
Cancer;
127(12): 2003-2014, 2021 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33626197
4.
Influence of polymorphisms in anthracyclines metabolism genes in the standard induction chemotherapy of acute myeloid leukemia.
Pharmacogenet Genomics;
31(6): 133-139, 2021 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33675324
5.
A phase I trial of selinexor plus FLAG-Ida for the treatment of refractory/relapsed adult acute myeloid leukemia patients.
Ann Hematol;
100(6): 1497-1508, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33914097
6.
Healthcare resource utilization in adult patients with relapsed/refractory FLT3 mutated acute myeloid leukemia: A retrospective chart review from Spain.
Eur J Haematol;
106(5): 724-733, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33609315
7.
Extracorporeal photopheresis vs standard therapies for steroid-refractory chronic graft-vs-host disease: Pharmacoeconomic assessment of hospital resource use in Spain.
J Clin Apher;
36(4): 612-620, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33964038
8.
Characteristics and outcome of adult patients with acute promyelocytic leukemia and increased body mass index treated with the PETHEMA Protocols.
Eur J Haematol;
104(3): 162-169, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31724208
9.
MIRROS: a randomized, placebo-controlled, Phase III trial of cytarabine ± idasanutlin in relapsed or refractory acute myeloid leukemia.
Future Oncol;
16(13): 807-815, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32167393
10.
Incidence and outcome of invasive fungal disease after front-line intensive chemotherapy in patients with acute myeloid leukemia: impact of antifungal prophylaxis.
Ann Hematol;
98(9): 2081-2088, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31240471
11.
Invasive fungal disease in patients undergoing umbilical cord blood transplantation after myeloablative conditioning regimen.
Eur J Haematol;
102(4): 331-340, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30506598
12.
Validation of a multivariable prediction model for post-engraftment invasive fungal disease in 465 adult allogeneic hematopoietic stem cell transplant recipients.
Mycoses;
62(5): 418-427, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30633829
13.
Correction to: A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia.
Ann Hematol;
97(5): 923, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29473097
14.
A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia.
Ann Hematol;
97(5): 763-772, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29392425
15.
Anti-D Alloimmunization after RhD-Positive Platelet Transfusion in RhD-Negative Women under 55 Years Diagnosed with Acute Leukemia: Results of a Retrospective Study.
Transfus Med Hemother;
45(3): 162-166, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29928170
16.
Assessment of late cardiomyopathy by magnetic resonance imaging in patients with acute promyelocytic leukaemia treated with all-trans retinoic acid and idarubicin.
Ann Hematol;
96(7): 1077-1084, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28451804
17.
A prognostic model for survival after salvage treatment with FLAG-Ida +/- gemtuzumab-ozogamicine in adult patients with refractory/relapsed acute myeloid leukaemia.
Br J Haematol;
174(5): 700-10, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27118319
18.
Phase II trial to assess the safety and efficacy of clofarabine in combination with low-dose cytarabine in elderly patients with acute myeloid leukemia.
Ann Hematol;
93(1): 43-6, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24081577
19.
Incidence and Risk Factors for Development of Cardiac Toxicity in Adult Patients with Newly Diagnosed Acute Myeloid Leukemia.
Cancers (Basel);
15(8)2023 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37190195
20.
Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group.
Blood Cancer J;
13(1): 77, 2023 05 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37173322